Renalis Works with University Hospitals for Proof of Concept Study
March 17, 2021
Cleveland, OH - Renalis today announces it will collaborate with University Hospitals (UH) to conduct a proof of concept study for a digital therapeutic treating overactive bladder (OAB).
Renalis’ software platform will be designed initially for persons assigned female at birth and will deliver individualized elements of behavioral therapy traditionally delivered in person by a pelvic floor physical therapist or nurse practitioner. In today’s healthcare environment of remote care, Renalis believes the addition of its innovation will dramatically enhance patient experiences and outcomes while reducing the administrative burden on the healthcare staff, and ultimately reducing costs. The company is planning to seek FDA approval as a software as a medical device.
Spearheading the team from the Urology Institute is Dr. David Sheyn, Division of Female Pelvic Medicine and Reconstructive Surgery, University Hospitals Urology Institute. “The treatment of OAB is limited by our lack of understanding of the many etiologies that can lead to this condition and lack of personalized treatment. Renalis’ technology could potentially create an individualized treatment paradigm to improve our clinical outcomes, and more importantly, the patient experience,” said Dr. Sheyn.
“University Hospitals is the perfect health system for our first product offering,” said Missy Lavender, Renalis CEO & Founder. “Dr. Sheyn brings his years of experience in biomedical engineering and deep interest in novel solutions for chronic conditions like OAB and adds clinical expertise to this important validating study of our platform. We look forward to this first step in what we believe will be a long and fruitful collaboration,” she added.
Renalis and UH expect to start recruiting patients in the second quarter of 2021.
For more information, please visit www.renalis.health
About Renalis
Renalis is a Cleveland-based software company committed to developing prescribed digital therapeutics (PDT) for pelvic health disorders. The company expects its first product for overactive bladder (OAB) to improve the effectiveness and efficiency of patient/provider interactions, optimize patient outcomes, and over time, decrease healthcare costs.
About University Hospitals / Cleveland, Ohio
Founded in 1866, University Hospitals serves the needs of patients through an integrated network of 20 hospitals (including 5 joint ventures), more than 50 health centers and outpatient facilities, and 200 physician offices in 16 counties throughout northern Ohio. The system’s flagship academic medical center, University Hospitals Cleveland Medical Center, located in Cleveland’s University Circle, is affiliated with Case Western Reserve University School of Medicine. The main campus also includes University Hospitals Rainbow Babies & Children's Hospital, ranked among the top children’s hospitals in the nation; University Hospitals MacDonald Women's Hospital, Ohio's only hospital for women; University Hospitals Harrington Heart & Vascular Institute, a high-volume national referral center for complex cardiovascular procedures; and University Hospitals Seidman Cancer Center, part of the NCI-designated Case Comprehensive Cancer Center. UH is home to some of the most prestigious clinical and research programs in the nation, including cancer, pediatrics, women's health, orthopedics, radiology, neuroscience, cardiology, and cardiovascular surgery, digestive health, transplantation, and urology. UH Cleveland Medical Center is perennially among the highest performers in national ranking surveys, including “America’s Best Hospitals” from U.S. News & World Report. UH is also home to Harrington Discovery Institute, part of The Harrington Project for Discovery & Development. UH is one of the largest employers in Northeast Ohio with 28,000 physicians and employees. Advancing the Science of Health and the Art of Compassion is UH’s vision for benefitting its patients into the future, and the organization’s unwavering mission is To Heal. To Teach. To Discover. Follow UH on LinkedIn, Facebook @UniversityHospitals, and Twitter @UHhospitals.
For more information, visit UHhospitals.org.
Contact: Missy Lavender, Founder, CEO
Email: missy@renalis.health
Phone: (312) 287-1951
